Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care

Lancet Haematol. 2021 Nov;8(11):e853-e861. doi: 10.1016/S2352-3026(21)00231-3. Epub 2021 Oct 5.

Abstract

Haematopoietic stem-cell transplantation (HSCT) has seen substantial growth among older adults. Chronological age is no longer viewed as an absolute barrier to HSCT, and alternative methods for assessing pre-transplantation fitness are increasingly used. In this Series paper, we summarise the metrics for pre-transplantation risk assessment in older adults, including both traditional metrics and geriatric assessment, and the ability of these metrics to predict post-transplantation outcomes. We also discuss strategies to broaden the utility of geriatric assessment, including in chronologically younger HSCT candidates and to guide individualised pre-transplantation interventions. Finally, we discuss donor considerations in older adults, including use of older sibling donors, haploidentical donors, and emerging data for donor-associated clonal haematopoiesis of indeterminate potential.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Donor Selection
  • Geriatric Assessment*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Risk Assessment
  • Transplantation, Homologous